Literature DB >> 31253988

5-Year Follow-up of Active Tuberculosis Development From Latent Infection in Rural China.

Henan Xin1, Haoran Zhang1, Shumin Yang2, Jianmin Liu3, Wei Lu4, Liqiong Bai5, Xuefang Cao1, Boxuan Feng1, Qi Jin1, Lei Gao1.   

Abstract

A 5-year follow-up study found declining disease development rates from latent tuberculosis infection. In the latter 3 years, the incidence, per 100 person-years, was 0.26 for interferon-γ release assay positives and 0.19 for tuberculin skin test positives (P = .28). In addition, all round have been checked.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cohort study; incidence; latent tuberculosis infection; tuberculosis

Mesh：

Year:  2020        PMID： 31253988     DOI： 10.1093/cid/ciz581

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  6 in total

1.  The Association between Circulating microRNAs and the Risk of Active Disease Development from Latent Tuberculosis Infection: a Nested Case-Control Study.

Authors:  Henan Xin; Xuefang Cao; Ying Du; Jiaoxia Yan; Rui He; Zisen Liu; Haoran Zhang; Yijun He; Bin Zhang; Dakuan Wang; Ling Guan; Fei Shen; Boxuan Feng; Zhusheng Quan; Yongpeng He; Jianmin Liu; Qi Jin; Shouguo Pan; Lei Gao
Journal:  Microbiol Spectr       Date:  2022-04-18

2.  Prevalence of Latent Tuberculosis Infection Among Healthy Young Children and Adolescents and a Two-step Approach for the Diagnosis of Tuberculosis Infection in Chengdu, China.

Authors:  Jihang Jia; Dapeng Chen; Li Liu; Mohd Jaish Siddiqui; Fan Yang; Yu Zhu; Qiong Liao; Shuanghong Luo; Min Shu; Yang Wen; Lihong Gao; Xu Li; Lilin Long; Xiaoshan Peng; Weiran Li; Yang Liu; Wanting Xu; Qian Han; Huaiyong Wu; Jiarong Guo; Xi Du; Qin Guo; Chaomin Wan
Journal:  Pediatr Infect Dis J       Date:  2022-01-01       Impact factor: 3.806

3.  Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial.

Authors:  Henan Xin; Xuefang Cao; Haoran Zhang; Boxuan Feng; Ying Du; Bin Zhang; Dakuan Wang; Zisen Liu; Ling Guan; Fei Shen; Xueling Guan; Jiaoxia Yan; Yijun He; Yongpeng He; Zhusheng Quan; Shouguo Pan; Jianmin Liu; Qi Jin; Lei Gao
Journal:  Eur Respir J       Date:  2022-07-07       Impact factor: 33.795

4.  Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection.

Authors:  Ying Luo; Guoxing Tang; Xu Yuan; Qun Lin; Liyan Mao; Huijuan Song; Ying Xue; Shiji Wu; Renren Ouyang; Hongyan Hou; Feng Wang; Ziyong Sun
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

5.  Mycobacterium tuberculosis-Specific T Cell Functional, Memory, and Activation Profiles in QuantiFERON-Reverters Are Consistent With Controlled Infection.

Authors:  Cheleka A M Mpande; Pia Steigler; Tessa Lloyd; Virginie Rozot; Boitumelo Mosito; Constance Schreuder; Timothy D Reid; Nicole Bilek; Morten Ruhwald; Jason R Andrews; Mark Hatherill; Francesca Little; Thomas J Scriba; Elisa Nemes
Journal:  Front Immunol       Date:  2021-08-30       Impact factor: 7.561

6.  Lymphocyte-Related Immunological Indicators for Stratifying Mycobacterium tuberculosis Infection.

Authors:  Ying Luo; Ying Xue; Guoxing Tang; Yimin Cai; Xu Yuan; Qun Lin; Huijuan Song; Wei Liu; Liyan Mao; Yu Zhou; Zhongju Chen; Yaowu Zhu; Weiyong Liu; Shiji Wu; Feng Wang; Ziyong Sun
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.